Exicure, Inc. is projected to rise to $1.67 by 2027, a +6% move from its current price of $1.58. XCUR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.50 | $1.58 | $1.67 | +0.03% |
| Aug 6 | $1.47 | $1.58 | $1.70 | +0.06% |
| Aug 7 | $1.44 | $1.58 | $1.73 | +0.09% |
| Aug 8 | $1.43 | $1.58 | $1.76 | +0.12% |
| Aug 9 | $1.41 | $1.58 | $1.78 | +0.15% |
| Aug 10 | $1.39 | $1.58 | $1.80 | +0.18% |
| Aug 11 | $1.38 | $1.58 | $1.82 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.38 | $1.58 | $1.82 | +0.21% |
| Week 2 | $1.31 | $1.59 | $1.93 | +0.43% |
| Week 3 | $1.25 | $1.59 | $2.02 | +0.64% |
| Week 4 | $1.21 | $1.59 | $2.10 | +0.86% |
| Week 5 | $1.17 | $1.60 | $2.17 | +1.07% |
| Week 6 | $1.14 | $1.60 | $2.24 | +1.29% |
| Week 7 | $1.11 | $1.60 | $2.31 | +1.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Exicure, Inc. is a healthcare company founded in 2011 and headquartered in Redwood City, California. It currently has limited operations and previously focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets.
The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas.
Exicure, Inc. trades at $1.57 per share and has a market cap of $10.01M. It is ranked 4805 in market position. The current price and market position place it among smaller-cap healthcare names.
A major floor 49.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
The nearest ceiling, 73.4% above — a clean break opens room to run.
A major ceiling 191.8% above — clearing it would confirm fresh momentum.
Key XCUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XCUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.68 | Sell | $1.66 | Sell |
| MA 10 | $1.74 | Sell | $1.71 | Sell |
| MA 20 | $1.75 | Sell | $1.82 | Sell |
| MA 50 | $2.31 | Sell | $2.27 | Sell |
| MA 100 | $3.07 | Sell | $2.89 | Sell |
| MA 200 | $3.93 | Sell | $3.88 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.20 | Neutral |
| Stoch RSI (14) | 35.50 | Neutral |
| CCI (20) | -110.80 | Sell |
| Williams %R (14) | -91.67 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -1.23 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 8.33 | Buy |
| TRIX (15) | -1.43 | Sell |
| Awesome (5,34) | -0.33 | Sell |
| Ultimate (7,14,28) | 31.87 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 1.62 | Sell |
| ADX (14) | 25.66 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 30. The 50-day simple moving average is $2.34 and the 200-day simple moving average is $3.95, with near-term support at $1.57 and resistance at $2.74. The 30-day price range runs from $1.10 to $2.23, reflecting a tight trading window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.57 | $1.58 | $2.14 | 0% | Neutral | |
| $1.22 | $1.67 | $2.46 | +6% | Neutral | |
| $1.03 | $1.50 | $2.36 | -5% | Neutral | |
| $0.7617 | $1.16 | $1.92 | -26% | Bearish | |
| $0.9208 | $1.47 | $2.53 | -7% | Neutral | |
| $1.07 | $1.78 | $3.17 | +13% | Neutral | |
| $1.05 | $1.82 | $3.33 | +15% | Neutral | |
| $1.12 | $2.03 | $3.82 | +28% | Bullish | |
| $0.9544 | $1.79 | $3.45 | +13% | Neutral | |
| $0.8337 | $1.62 | $3.20 | +3% | Neutral | |
| $0.9903 | $2.20 | $4.77 | +39% | Bullish | |
| $2.10 | $4.67 | $10.74 | +195% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.57 | $1.58 | $1.84 | +0.00% |
| September 2026 | $1.26 | $1.53 | $1.93 | -3.33% |
| October 2026 | $1.32 | $1.62 | $2.10 | +6.36% |
| November 2026 | $1.30 | $1.61 | $2.11 | -0.73% |
| December 2026 | $1.28 | $1.61 | $2.14 | -0.02% |
Click any year to see its month-by-month XCUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect XCUR to range from $1.57 to $2.14 through 2026. The $1.58 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The XCUR price prediction for 2027 points to an average of $1.67 (low $1.22, high $2.46) — a potential gain of +6% on today's $1.58. Price action looks broadly range-bound.
In 2028, XCUR is projected to trade between $1.03 and $2.36, averaging $1.50 — a potential decline of -5% from today's $1.58. That is -10% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Exicure, Inc.'s 2029 outlook centres on $1.16, within a $0.7617 to $1.92 range. That is -22% versus the projected 2028 average. That marks a -26% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, XCUR could reach as high as $2.53, with a base case around $1.47 and support toward $0.9208 — roughly -7% from $1.58. A consolidation phase looks the most probable path here.
Expect XCUR to range from $1.07 to $3.17 through 2031. The $1.78 average target implies a +13% move from current prices. That is up +21% on the projected 2030 average. Price action looks broadly range-bound.
The XCUR price prediction for 2032 points to an average of $1.82 (low $1.05, high $3.33) — a potential gain of +15% on today's $1.58. A consolidation phase looks the most probable path here.
In 2033, XCUR is projected to trade between $1.12 and $3.82, averaging $2.03 — a potential gain of +28% from today's $1.58. That is up +12% on the projected 2032 average. Momentum favours further upside here.
Exicure, Inc.'s 2034 outlook centres on $1.79, within a $0.9544 to $3.45 range. That is -12% versus the projected 2033 average. That marks a +13% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, XCUR could reach as high as $3.20, with a base case around $1.62 and support toward $0.8337 — roughly +3% from $1.58. Price action looks broadly range-bound.
Expect XCUR to range from $0.9903 to $4.77 through 2040. The $2.20 average target implies a +39% move from current prices. That is up +36% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The XCUR price prediction for 2050 points to an average of $4.67 (low $2.10, high $10.74) — a potential gain of +195% on today's $1.58. Momentum favours further upside here.
Investing $1,000 in XCUR today (≈ 632.911392 XCUR) could be worth
$2,954.42
+$1,954.42 (+195%) by 2050 · US Dollar
Based on the average projected XCUR price of $4.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XCURwould be worth at today's price.
$1,000 invested in XCUR on Jul 31, 2025 (≈ 140.252452 XCUR) would be worth
$221.6
-$778.4 (-77.8%) today · 0.22× · US Dollar
Based on a XCUR entry price of $7.13 vs. today's $1.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.76 | $897.73 | -10.2% |
| 1 month ago | $1.98 | $797.98 | -20.2% |
| 3 months ago | $3.24 | $487.65 | -51.2% |
| 6 months ago | $4.2 | $376.19 | -62.4% |
| 1 year ago | $7.13 | $221.6 | -77.8% |
| All time (5.0y) ago | $198 | $7.98 | -99.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XCUR forecast.
Our base-case forecast reaches $3.20 around 2050.
Implied market cap at $3.20: $20.4M
The multi-year forecast shows a mixed path with early years generally flat to modestly rising and later years showing more pronounced movement. For 2026 the avg is $1.57 with a min of $1.57 and a max of $2.16 and ROI 0, followed by 2027 with avg $1.67 and ROI 6.1. The 2030 forecast shows an avg of $1.46 with ROI -6.7, while 2040 projects an avg of $2.15 with ROI 37.2 and a bullish sentiment, and 2050 points to an avg of $4.69 with ROI 198.8 and a bullish sentiment.
The path includes a bullish turn in 2033 (avg $2.04, ROI 29.6) and continued potential into 2040 and 2050, but also notable downside in 2029 (avg $1.15, ROI -26.5). These are estimates, not guarantees, and depend on evolving market conditions and company developments.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.46 with a range from $0.9078 to $2.54. The ROI is -6.7% and the sentiment is NEUTRAL.
Forecasts show a mix of outcomes: 2033 is bullish with an average of $2.04 and ROI 29.6, while 2029 is bearish with an average of $1.15 and ROI -26.5. The path includes years with small gains and years with declines, so results are uncertain and not guaranteed.
Yes. The 2050 maximum forecast is $10.79, indicating potential upside in the longer term.
RSI 14 is 30, with a 50-day SMA of $2.34 and a 200-day SMA of $3.95. Support is at $1.57 and resistance at $2.74, and the 30-day range is $1.10 to $2.23.
For 2040, the avg is $2.15 with a min of $0.9693 and a max of $4.72, ROI 37.2, and sentiment BULLISH.
Exicure, Inc. Community Discussion
0Share your Exicure, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.